These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 7595233)

  • 21. An exhaustion-like phenotype constrains the activity of CD4+ T cells specific for a self and melanoma antigen.
    Rausch MP; Hastings KT
    PLoS One; 2015; 10(4):e0123332. PubMed ID: 25875653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of antitumor immunity with dendritic cells transduced with adenovirus vector-encoding endogenous tumor-associated antigens.
    Kaplan JM; Yu Q; Piraino ST; Pennington SE; Shankara S; Woodworth LA; Roberts BL
    J Immunol; 1999 Jul; 163(2):699-707. PubMed ID: 10395660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dendritic cells transduced with gp100 gene by RGD fiber-mutant adenovirus vectors are highly efficacious in generating anti-B16BL6 melanoma immunity in mice.
    Okada N; Masunaga Y; Okada Y; Mizuguchi H; Iiyama S; Mori N; Sasaki A; Nakagawa S; Mayumi T; Hayakawa T; Fujita T; Yamamoto A
    Gene Ther; 2003 Oct; 10(22):1891-902. PubMed ID: 14502218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adoptive transfer enables tumor rejection targeted against a self-antigen without the induction of autoimmunity.
    Eck SC; Turka LA
    Cancer Res; 2001 Apr; 61(7):3077-83. PubMed ID: 11306490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunotherapeutic targeting of shared melanoma-associated antigens in a murine glioma model.
    Prins RM; Odesa SK; Liau LM
    Cancer Res; 2003 Dec; 63(23):8487-91. PubMed ID: 14679014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dendritic cell-based genetic immunization in mice with a recombinant adenovirus encoding murine TRP2 induces effective anti-melanoma immunity.
    Tüting T; Steitz J; Brück J; Gambotto A; Steinbrink K; DeLeo AB; Robbins P; Knop J; Enk AH
    J Gene Med; 1999; 1(6):400-6. PubMed ID: 10753065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoantibodies to tyrosinase: the bridge between melanoma and vitiligo.
    Fishman P; Merimski O; Baharav E; Shoenfeld Y
    Cancer; 1997 Apr; 79(8):1461-4. PubMed ID: 9118024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytotoxic T lymphocyte reactivity to gp100, MelanA/MART-1, and tyrosinase, in HLA-A2-positive vitiligo patients.
    Mandelcorn-Monson RL; Shear NH; Yau E; Sambhara S; Barber BH; Spaner D; DeBenedette MA
    J Invest Dermatol; 2003 Sep; 121(3):550-6. PubMed ID: 12925214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced suppression of melanoma tumor growth and metastasis by combined therapy with anti-VEGF receptor and anti-TYRP-1/gp75 monoclonal antibodies.
    Patel D; Bassi R; Hooper AT; Sun H; Huber J; Hicklin DJ; Kang X
    Anticancer Res; 2008; 28(5A):2679-86. PubMed ID: 19035294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Melanoma progression despite infiltration by in vivo-primed TRP-2-specific T cells.
    Singh V; Ji Q; Feigenbaum L; Leighty RM; Hurwitz AA
    J Immunother; 2009; 32(2):129-39. PubMed ID: 19238011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic efficacy of antigen-specific vaccination and toll-like receptor stimulation against established transplanted and autochthonous melanoma in mice.
    Tormo D; Ferrer A; Bosch P; Gaffal E; Basner-Tschakarjan E; Wenzel J; Tüting T
    Cancer Res; 2006 May; 66(10):5427-35. PubMed ID: 16707471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NK and CD8+ T cell-mediated eradication of poorly immunogenic B16-F10 melanoma by the combined action of IL-12 gene therapy and 4-1BB costimulation.
    Xu D; Gu P; Pan PY; Li Q; Sato AI; Chen SH
    Int J Cancer; 2004 Apr; 109(4):499-506. PubMed ID: 14991570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effective induction of therapeutic antitumor immunity by dendritic cells coexpressing interleukin-18 and tumor antigen.
    Xia D; Zheng S; Zhang W; He L; Wang Q; Pan J; Zhang L; Wang J; Cao X
    J Mol Med (Berl); 2003 Sep; 81(9):585-96. PubMed ID: 12937899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recognition of autoantigens by patients with melanoma.
    Houghton AN; Vijayasaradhi S; Bouchard B; Naftzger C; Hara I; Chapman PB
    Ann N Y Acad Sci; 1993 Aug; 690():59-68. PubMed ID: 8368771
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunization with DNA coding for gp100 results in CD4 T-cell independent antitumor immunity.
    Hawkins WG; Gold JS; Dyall R; Wolchok JD; Hoos A; Bowne WB; Srinivasan R; Houghton AN; Lewis JJ
    Surgery; 2000 Aug; 128(2):273-80. PubMed ID: 10923004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic immunization of mice with human tyrosinase-related protein 2: implications for the immunotherapy of melanoma.
    Steitz J; Brück J; Steinbrink K; Enk A; Knop J; Tüting T
    Int J Cancer; 2000 Apr; 86(1):89-94. PubMed ID: 10728600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unraveling the complex relationship between cancer immunity and autoimmunity: lessons from melanoma and vitiligo.
    Uchi H; Stan R; Turk MJ; Engelhorn ME; Rizzuto GA; Goldberg SM; Wolchok JD; Houghton AN
    Adv Immunol; 2006; 90():215-41. PubMed ID: 16730265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aire deficiency promotes TRP-1-specific immune rejection of melanoma.
    Zhu ML; Nagavalli A; Su MA
    Cancer Res; 2013 Apr; 73(7):2104-16. PubMed ID: 23370329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunotherapy can reject intracranial tumor cells without damaging the brain despite sharing the target antigen.
    Bridle BW; Li J; Jiang S; Chang R; Lichty BD; Bramson JL; Wan Y
    J Immunol; 2010 Apr; 184(8):4269-75. PubMed ID: 20237288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune rejection of mouse tumors expressing mutated self.
    Duan F; Lin Y; Liu C; Engelhorn ME; Cohen AD; Curran M; Sakaguchi S; Merghoub T; Terzulli S; Wolchok JD; Houghton AN
    Cancer Res; 2009 Apr; 69(8):3545-53. PubMed ID: 19351857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.